[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.226.234.102. Please contact the publisher to request reinstatement.
Editorial
Feb 2012

Changing Scenery of Eye Care in China: From Cataract to Diabetic Retinopathy

Author Affiliations

Author Affiliations: Department of Ophthalmology and Pathology, Wilmer Eye Institute, The Johns Hopkins University, Baltimore, Maryland; Peking University Eye Center, Beijing, China; and Directorate of Education, International Council of Ophthalmology.

Arch Ophthalmol. 2012;130(2):243-245. doi:10.1001/archopthalmol.2011.1663

Since the 1978 China Economic Reform initiated by Chinese leader Deng Xiao Ping, the average annual growth in China's gross domestic product (GDP) is 10.9% (2003-2008).1 This remarkable economic growth, with a degree of openness, has helped change eye care in China at a dramatic pace. However, to reform the eye care of a developing country with a population of 1336.3 million with diverse ethnic backgrounds spreading over 9 560 900 km2, a GDP per head of only $3270 (2011 US dollars), and health spending of 4.3% GDP (2011), a multichanneled approach is necessary.1 To grasp a proper perspective for this spectacular journey, 4 stages may be sketched.

×